Cali, Colombia, Key learning City C/Can 2025: City Cancer Challenge
Article Sidebar
Main Article Content
Cali (Colombia) will be the first city in the world to implement the initiative “C/Can 2025: City Cancer Challenge”1 (http://www.uicc.org/what-we-do/convening/ccan-2025-city-cancer-challenge). With 2.4 million inhabitants, Cali is the second-largest city of Colombia and a key urban focal point for the immigration of the country’s rural population which represents one fifth of Colombia’s 45.5 million inhabitants.
- Cancer
- c/can 2025
- Cali
- Colombia
- Union for International Cancer Control
Adams C, Henshall S, Torode J, D’Cruz AK, Kumar HS, Aranda S. C/Can 2025: City Cancer Challenge, a new initiative to improve cancer care in cities. Lancet Oncol. 2017; 18(3): 286-7. DOI: https://doi.org/10.1016/S1470-2045(17)30083-9
C/Can 2025 City Cancer Challenge. Guiding Principles for Quality Cancer Treatment Services in Cities. Geneva: Union for International Cancer Control; 2017.
Aguilera LJ, Murcia MEM. Servicios Oncológicos de Colombia. Boletín de Servicios Oncológicos, Instituto Nacional de Cancerología. 2016. Available from: http://www.cancer.gov.co/files/libros/archivos/%20Servicios%20Oncologicos%20Bolet%C3%ADn.pdf.
Bravo LE, Collazos T, Collazos P, García LS, Correa P. Trends of cancer incidence and mortality in Cali, Colombia. 50 years experience. Colomb Med (Cali). 2012; 43(4): 246-55. DOI: https://doi.org/10.25100/cm.v43i4.1266
Bravo LE, García LS, Collazos P, Aristizabal P, Ramirez O. Descriptive epidemiology of childhood cancer in Cali: Colombia 1977-2011. Colomb Med (Cali). 2013; 44(3): 155-64. DOI: https://doi.org/10.25100/cm.v44i3.1243
Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet. 2015; 385(9972): 977-1010. DOI: https://doi.org/10.1016/S0140-6736(14)62038-9
Ospina-Romero M, Portilla CA, Bravo LE, Ramirez O, VIGICANCER working group . Caregivers’ self-reported absence of social support networks is related to treatment abandonment in children with cancer. Pediatr Blood Cancer. 2016; 63: 825-31. DOI: https://doi.org/10.1002/pbc.25919
Downloads
- Luis Eduardo Bravo, Estimating the incidence and mortality of cancer in Colombia: What are the best data for public policies? , Colombia Medica: Vol. 47 No. 2 (2016)
- Clara I. Campos, Luis Eduardo Bravo, Los clínicos son de marte y los patólogos de venus. Interpretación clínica de los informes de patología. , Colombia Medica: Vol. 32 No. 4 (2001)
- Maria Clara Yepez, Luis Eduardo Bravo, Arsenio Hidalgo Troya, Daniel Marcelo Jurado, Luisa Mercedes Bravo, Cancer incidence and mortality in the municipality of Pasto, 1998 – 2007 , Colombia Medica: Vol. 43 No. 4 (2012): Numbers in cancer: 50-year of The Population-based Cancer Registry of Cali
- Alejandra Saldarriaga-Cantillo, Oscar Londoño, Luz Stella García, Paola Collazos, Luis Eduardo Bravo, Epidemiological surveillance of the HIV/AIDS complex through the analysis of trends in the incidence of Kaposi’s sarcoma in Cali, Colombia , Colombia Medica: Vol. 43 No. 4 (2012): Numbers in cancer: 50-year of The Population-based Cancer Registry of Cali
- Luz Stella García, Luis Eduardo Bravo, Paola Collazos, Oscar Ramírez, Edwin Carrascal, Marcela Nuñez, Nelson Portilla, Erquinovaldo Millan, Cali Cancer Registry Methods , Colombia Medica: Vol. 49 No. 2 (2018)
- Luis Eduardo Bravo, Juan Carlos Bravo, José Luis Realpe, Guillermo Zarama, María Blanca Piazuelo, Pelayo Correa, Source of variation in the diagnosis of Helicobacter pylori-associated multifocal atrophic gastritis. , Colombia Medica: Vol. 39 No. 1 (2008)
- Luis Eduardo Bravo, Luz Stella García, Paola Andrea Collazos, Cancer survival in Cali, Colombia: A population-based study, 1995-2004 , Colombia Medica: Vol. 46 No. 1 (2015)
- Luis Eduardo Bravo, Helicobacter pylori y la patogénesis de la gastritis y la úlcera. Premio Nobel en Medicina y Fisiología. , Colombia Medica: Vol. 37 No. 3 (2006)
- Ramiro Pinedo, César Neira, Luis Eduardo Bravo, Angiomixoma agresivo: Informe de casos y revisión de literatura , Colombia Medica: Vol. 26 No. 3 (1995)
- Luis Eduardo Bravo, Pablo Barreto, Norwegian scabies in a patient with adult T-cell lymphoma/leukemia , Colombia Medica: Vol. 18 No. 2 (1987)
Similar Articles
- Luis Eduardo Bravo, Luz Stella Garcia, Paola Collazos, Jorge Alirio Holguin, Isabelle Soerjomataram, Adalberto Miranda-Filho, Trends in long-term cancer survival in Cali, Colombia: 1998-2017 , Colombia Medica: Vol. 53 No. 1 (2022): Cancer incidence and mortality
- Luis Eduardo Bravo, Nubia Muñoz, Epidemiology of cancer in Colombia , Colombia Medica: Vol. 49 No. 1 (2018): Colombia Cancer Epidemiology
- María Clara Yepez Chamorro, Daniel Marcelo Jurado Fajardo, Luisa Mercedes Bravo Goyes, Luis Eduardo Bravo Ocaña, Trends in cancer incidence, mortality and survival in Pasto, Colombia , Colombia Medica: Vol. 49 No. 1 (2018): Colombia Cancer Epidemiology
You may also start an advanced similarity search for this article.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use